Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

5% minoxidil works better for hair growth than 1% minoxidil.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Cynatine HNS improves hair and nail quality in 90 days.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

JetPeel-assisted minoxidil improves hair density and thickness more than minoxidil alone.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

Rice bran extract caused moderate skin irritation but no eye irritation, while a diluted essence was not irritating to skin and only slightly to guinea pigs.

The moisturizer with phytol improved skin texture and reduced fine wrinkles better than the moisturizer without it.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

NX35growth™ effectively promotes hair growth and improves hair health.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

No cure for female pattern hair loss, but various effective treatments exist.